Cytomegalovirus (CMV) inSIGHT™ T Cell Immunity testing

Alphabetical Test listing

Cytomegalovirus (CMV) inSIGHT™ T Cell Immunity testing-994

  
Cytomegalovirus (CMV) inSIGHT™ T Cell Immunity testing
  
994
  
LAB994
  
MSO
  

The CMV inSIGHT™ T Cell Immunity Panel measures the strength of T cell responses to Cytomegalovirus (CMV) specific antigens. It evaluates and reports the activity of CD4 and CD8 T cell responses independently.  Effective T cell immunity against CMV is a factor in controlling CMV viral latency.  CMV can affect patients with weakened immune systems and is a common risk factor in patients following solid organ or hematopoietic stem cell transplant.

  
Sodium heparin (Na hep) whole blood
  
10 mL
  
7.5 mL
3.0 mL (pediatric)
  
  • Collect Monday through Friday only
  • Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times, to prevent clotting
  • Tube must be at least ¾ full to maintain proper ratio of blood to anticoagulant
  

Dk green Sodium heparin (Na hep), no gel, 10mL

  
  

Dk green Sodium heparin (Na hep), no gel, 4mL x 2

  

Ambient (strict) - 32 hours

Refrigerated - NO

Frozen - NO

Must be received within 32 hours from collection

  
  • Whole blood received after stability (32 hours after collection)
  • Whole blood received cold or frozen
  • Tubes received less than 3/4 full
  • Specimens received in lithium heparin, ACD or EDTA anticoagulants.
  
Viracor Eurofins (30360) via LabCorp (009985): R-NX
  
7 days
  

Flow Cytometry

  

See report

  
86352 x 4
  
Yes
  
  
06/20/2022
  
06/20/2022